Delivery Order SPE2DB25D3012-SPE2DB25FWWNT

Award Date 3/31/25
Potential Completion Date 4/1/25
Potential Value $3.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of CLONIDINE HCL ER 0.1 MG TABLET 60S, a prescription medication, to support military treatment programs and facilities. The contract has a ceiling value of $2,241.62 and a completion date of March...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,012.72 and a performance period through July 3, 2025. The award is for the supply of Clonidine HCL ER 0.1 MG Tablets in 60-count packages. This pharmaceutical product is used to treat various medical...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,560.14 firm fixed-price contract is for the delivery of the prescription medication Clonidine 0.3 mg/day patches. The contract has an ultimate completion date of July 3, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not designated as a set-aside. The company holds a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Medical Supply Chain division of the Defense Logistics Agency (DLA). The contract, valued at $44,826.67, is for the delivery of CHLORDIAZEPOXIDE-CLIDINIUM CAP 100S medication. It is a firm fixed price delivery order contract with a performance period through January 30, 2025. The contract was awarded on January 29, 2025 and does not have a set-aside...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $1,136.97 with a completion date of July 16, 2024. It is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $5,063.79 firm-fixed-price delivery order is for the supply of 10-unit dosage CLOMID 50 MG TABLET. The award has an ultimate completion date of October 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $21,749.88, is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999.00. The contract is for the delivery of a variety of pharmaceutical products and medical supplies, including medications across multiple...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,851.81 firm fixed-price contract is for the procurement of CLENPIQ 175 ML SOLUTION 175ML, a pharmaceutical product. The contract has an ultimate completion date of April 25, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a $14,623.74 firm-fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide a variety of pharmaceutical products and medical supplies to support military healthcare programs. The contract has an ultimate completion date of July 1, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,359.13 firm fixed price delivery order is for the supply of 4568513111 - CLINDAMYCIN 150MG 100S, a pharmaceutical product. The contract has an ultimate completion date of July 10, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
  • SPE2DB25D3012
    Indefinite Delivery Contract
  • SPE2DB25D3012-SPE2DB25FWWNT
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $3,219.94, is a Delivery Order for the supply of CLONIDINE HCL ER 0.1 MG TABLET 60S. The contract has an ultimate completion date of April 1, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. There was no set-aside designation for this contract award.

Generated 6/30/25, 10:48 AM